Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05299983 · ClinicalTrials.gov registry record · NA
MyMenoPlan: Online Resource for Improving Women's Menopause Knowledge and Informed Decision-making
A NA study of Menopause and Postmenopause, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 410
- Enrollment target
- 1
- Study location
NCT05299983: Completed NA study of Menopause and Postmenopause, sponsored by University of California, San Diego.
NCT05299983 is a NA study of Menopause and Postmenopause that has completed, run by University of California, San Diego. The registered enrollment target is 410 participants, below the 9,387-participant average among 54 other Menopause trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05299983, a NA study of Menopause and Postmenopause, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 410 participants
- Enrollment target
- 1
- Study location
Study Summary
As part of a National Institute on Aging -funded R01, the investigators developed an evidence-based, multi-media digital resource entitled MyMenoPlan to help women learn about the menopause transition, and the symptoms and treatments of perimenopause/menopause. MyMenoPlan is also designed to help women learn about the effectiveness of treatments for a comprehensive list of midlife symptoms and compare treatments that may help with the specific symptoms women are experiencing.
Primary Outcome
This 7-item, 5-point Likert scale (1- Strongly disagree to 5 - Strongly agree) is adapted from the Post-Study System Usability Questionnaire (PSSUQ) in Lewis (1995). The range of this scale is 1-5. The items in this scale were averaged with a higher score meaning higher on this outcome (perceived quality of information). Items: 1. Reading the information made me feel in more control of my perimenopause/menopause. 2. The information on the website(s) was helpful to me. 3. I found the informatio
Conditions Studied
Interventions
- OTHER Control
- OTHER MyMenoPlan
Study Locations (1)
California
- UC San Diego - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 410 participants |
| Start Date | 2022-01-15 |
| Est. Completion | 2022-03-31 |
| Phase | NA |
What the finished NCT05299983 record still lists
NCT05299983 is an interventional study that assigns participants to a tested intervention. The registered 410 participants enrollment target is mid-sized for trials with a published cap, below the 9,387-participant average among 54 other Menopause trials with a reported enrollment target (96% lower).
The record links to 3 conditions, with Menopause appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT05299983 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05299983 about?
NCT05299983 is a clinical study titled "MyMenoPlan: Online Resource for Improving Women's Menopause Knowledge and Informed Decision-making". As part of a National Institute on Aging -funded R01, the investigators developed an evidence-based, multi-media digital resource entitled MyMenoPlan to help women learn about the menopause transition, and the symptoms and treatments of perimenopause/menopause. MyMenoPlan is also designed to help wo...
What is the current status of trial NCT05299983?
This trial is currently completed. It is a NA study. The enrollment target is 410 participants. The study started on 2022-01-15. Estimated completion is 2022-03-31.
What conditions does trial NCT05299983 study?
This clinical trial studies the following conditions: Menopause, Postmenopause, Premenopause.
What interventions are being tested in trial NCT05299983?
The interventions under investigation include: Control (OTHER), MyMenoPlan (OTHER).
Who is sponsoring clinical trial NCT05299983?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05299983 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Menopause
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05299983's enrollment target sits among peer trials
410 5th of 54 higher than 50 of 54 other Menopause trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Menopause trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hot Flashes and Neurovascular Function in Women
RECRUITING · NA
-
Efficacy and Safety of Shatavari for Treatment of Menopausal Symptoms in Women: A Randomized, Double-blind, Three-arm, Parallel, Placebo-controlled Study
RECRUITING · NA
-
Improving Sympathetic Activity, Hot Flashes, and Sleep in Midlife Women Using Inspiratory Muscle Strength Training
RECRUITING · NA
-
Exercise Training Intensity and Nitrate Supplementation in Post-Menopausal Females
RECRUITING · NA
-
Depression, Aging, Stress and Heart Health Study
RECRUITING · NA
-
Choline Dose Ranging in Postmenopausal Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02043691 · 410 participants · NA
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
- NCT03042975 · 410 participants
Imaging Genetics of Laryngeal Dystonia
- NCT05730036 · 410 participants · Phase 3
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
- NCT05751473 · 410 participants · NA
Reducing Posttraumatic Stress Disorder (PTSD) Symptoms in First Responders and Frontline Health Care Workers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI